RPL35AP13

Across TCGA pan-cancer cohorts, RPL35AP13 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPL35AP13’s most consistent transcriptional readouts.

The strongest signal is observed in rectum adenocarcinoma (READ), where RPL35AP13 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL35AP13 is over-expressed in tumor, although a few such as READ and THCA show the opposite, repressed pattern.

READ, THCA, and COAD are the cancer types where RPL35AP13 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL35AP13 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
READ	Male	All	−0.229	.001	5	view →
THCA	All	II,III,IV	−0.200	.001	5	view →
COAD	All	All	+0.387	.002	4	view →
HNSC	All	II,III,IV	+0.087	.028	4	view →
LUAD	Male	All	+0.617	.036	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RPL35AP13–READ

Open the READ breakdown →